ascorbic-acid and Tuberculosis--Meningeal

ascorbic-acid has been researched along with Tuberculosis--Meningeal* in 4 studies

Other Studies

4 other study(ies) available for ascorbic-acid and Tuberculosis--Meningeal

ArticleYear
Changes in vitamin C and oxidative stress status during the treatment of tuberculous meningitis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:11

    Tuberculosis (TB) is associated with oxidative stress and is traditionally linked to vitamin C deficiency.. To evaluate the time course of the oxidative stress marker, malondialdehyde (MDA), and vitamin C status during the clinical treatment of tuberculous meningitis (TBM).. MDA and vitamin C reduction/oxidation (redox) status were spectrophotometrically measured at admission and during hospital treatment in cerebrospinal fluid (CSF) and serum from 27 TBM patients and 20 controls.. Baseline CSF and serum MDA levels in TBM patients were higher than in controls (both P < 0.05), and remained elevated throughout the study. CSF MDA steadily increased from baseline 0.66 ± 0.24 mol/l to 1.02 ± 0.33 μmol/l at the end of the sixth week of treatment (P < 0.05), and then returned to baseline levels. Baseline CSF and serum total vitamin C were lower in TBM patients than in controls, but were soon normalised. CSF and serum ascorbate, reduced/oxidised vitamin C ratios and ascorbate CSF/serum ratio were markedly decreased in TBM patients (P < 0.05), and showed no improvement during treatment.. These results indicate increased local and systemic oxidative stress, accompanied by impaired redox status, but not total vitamin C deficiency, which persisted during conventional clinical treatment of TBM.

    Topics: Antitubercular Agents; Ascorbic Acid; Ascorbic Acid Deficiency; Biomarkers; Case-Control Studies; Child; Child, Preschool; Female; Humans; Infant; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Spectrophotometry; Time Factors; Treatment Outcome; Tuberculosis, Meningeal

2013
A new method for the manufacture of bis(4-aminophenyl)-sulfone and the anti-leprosy, anti-tuberculosis, and antibiotic activities of some new derivatives related to the drug. I.
    Arzneimittel-Forschung, 1967, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Ascorbic Acid; Bacteria; Cholera; Dapsone; Dysentery, Bacillary; Female; Heterocyclic Compounds; Humans; Leprosy; Meningitis; Meningitis, Haemophilus; Methods; Otorhinolaryngologic Diseases; Pregnancy; Puerperal Infection; Scarlet Fever; Sulfathiazoles; Sulfones; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Urinary Tract Infections; Vitamin K

1967
[EXCRETION OF VITAMIN C AND B2 IN THE URINE OF PATIENTS WITH TUBERCULOUS MENINGITIS].
    Sovetskaia meditsina, 1964, Volume: 28

    Topics: Ascorbic Acid; Ascorbic Acid Deficiency; Body Fluids; Drug Therapy; Humans; Riboflavin; Riboflavin Deficiency; Tuberculosis; Tuberculosis, Meningeal; Urine; Vitamins

1964
[Orientative research on the relation of vitamins of permeability and the hematoencephalic barrier in meningeal tuberculosis].
    Rivista di clinica pediatrica, 1954, Volume: 54, Issue:1

    Topics: Ascorbic Acid; Blood-Brain Barrier; Flavonoids; Humans; Permeability; Tuberculosis; Tuberculosis, Meningeal; Vitamin A; Vitamin K; Vitamins

1954